The expression levels of CCR5, CCL4, and CCL5 in AML cells are closely correlated with the prognosis for AML patients [27,32,39,100,101], indicating that the CCL4/CCL5–CCR5 axis is important in AML tumorigenesis (Table 4). This evidence concerns the gene CCL5 and acute myeloid leukemia.